Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial multiple meningioma is a rare, benign neoplasm of the central nervous system characterized by the development of multiple or, rarely, solitary meningiomas in two or more blood relatives, without other apparent syndromic manifestations. Depending on the localization, growth rate and size of the tumors, patients can present with subtle, gradually worsening or abrupt and severe neurological compromise or can be completely asymptomatic.
Biomarker and diagnostic research for familial multiple meningioma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for familial multiple meningioma.
76 publications have been identified in PubMed for familial multiple meningioma. Research spans Review / Meta-Analysis (26%), Case Report / Case Series (26%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 19 | 26% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
19 |
26% |
Disease patterns and progression | 14 | 19% |
Laboratory research | 9 | 13% |
Testing and diagnosis research | 3 | 4% |
Clinical study results | 3 | 4% |
New treatment approaches | 3 | 4% |
Other research | 2 | 3% |
Valdivia D (2026). [PMID: 42111420](https://pubmed.ncbi.nlm.nih.gov/42111420/). *Radiol Case Rep*. [Case Report / Case Series]
Shanahan RM (2026). [PMID: 41961774](https://pubmed.ncbi.nlm.nih.gov/41961774/). *Pediatr Neurosurg*. [Clinical Trial Publication]
Li L (2026). [PMID: 42180104](https://pubmed.ncbi.nlm.nih.gov/42180104/). *Front Oncol*. [Case Report / Case Series]
Aggarwal A (2026). [PMID: 41476144](https://pubmed.ncbi.nlm.nih.gov/41476144/). *Neuro Oncol*. [Basic Science / Preclinical]
Singuepire A (2026). [PMID: 41952931](https://pubmed.ncbi.nlm.nih.gov/41952931/). *Cureus*. [Case Report / Case Series]
Ramsey KA (2026). [PMID: 41670784](https://pubmed.ncbi.nlm.nih.gov/41670784/). *J Neurooncol*. [Case Report / Case Series]
Lusk EN (2026). [PMID: 42004902](https://pubmed.ncbi.nlm.nih.gov/42004902/). *Mol Genet Metab Rep*. [Review / Meta-Analysis]
Braman BC (2026). [PMID: 41230569](https://pubmed.ncbi.nlm.nih.gov/41230569/). *Neuro Oncol*. [Epidemiology / Natural History]
Mehrdad V (2026). [PMID: 41699156](https://pubmed.ncbi.nlm.nih.gov/41699156/). *Sci Rep*. [Diagnostic / Biomarker]
Nieva Posso DA (2026). [PMID: 41654683](https://pubmed.ncbi.nlm.nih.gov/41654683/). *Cell Mol Neurobiol*. [Review / Meta-Analysis]